CAR-T's Tightrope Walk: Why Autolus Faces an Uphill Battle Despite a Breakthrough
Biotech's Pulse: Gene-Editing's Leap, Cancer's New Fights, and What's Stirring the Industry
Beyond the Horizon: Manipal's Groundbreaking Conclave Illuminates Cell Therapy's Potential
The Quiet Revolution: Unpacking the Billions Behind Biotech's Essential Cell Banks
Immatics Unveils Groundbreaking Anzu-cel Data: A New Dawn for Metastatic Uveal Melanoma Patients at ESMO 2025
Sana Biotech Skyrockets: Eric Jackson's Bold Endorsement Fuels 50% Surge
Novo Nordisk Shifts Focus: Why the Cell Therapy Unit is Closing Its Doors
Unlocking Tomorrow's Cures: Bristol Myers Squibb's Daring Dive into Next-Gen Autoimmune Cell Therapies
Unlocking the Future of Medicine: Scientists Tackle Immune Rejection in Stem Cell Therapy
A New Dawn for Medicine: Florida Engineers Dramatically Scale Up Extracellular Vesicle Production
Revolutionizing Healthcare: The Exploding Exosome, Cell, and Gene Therapy Market
Revolutionizing Medicine: Tiny Genetic Switches Promise Safer, Smarter Therapies
A New Dawn in Oncology: Kite Pharma's $350 Million Acquisition of Interius Biotherapeutics Set to Revolutionize CAR T-Cell Therapy
Brainstorm Cell Therapeutics Unveils Robust Q2 2025 Financials and Pivotal Clinical Advancements